評(píng)論
打印
A diabetes pill has been shown, for the first time, to reduce deaths among patients taking it.
首次有種糖尿病藥片能夠減少服用該藥的病人死亡率。
It's a big finding — and Lilly, the drug company that makes it, is trumpeting the results.
這是一項(xiàng)重大發(fā)現(xiàn)。制作該藥物的禮來(lái)公司正為這一結(jié)果大肆慶祝。
An international group of researchers reported in The New England Journal of Medicine that the drug, called Jardiance, lowered heart disease deaths by 38 percent and deaths from any cause by 32 percent over three years.
一群國(guó)際研究人員在新英格蘭醫(yī)學(xué)雜志上報(bào)道稱(chēng)該藥物，名為恩格列凈，三年以來(lái)將心臟病的死亡率降低了38%，將任何原因?qū)е碌乃劳雎式档土?2%。
But doctors are not sure how the drug is doing it.
但是醫(yī)生們還不清楚這種藥物是如何發(fā)揮作用的。
Cardiologist Dr. Steve Nissen of the Cleveland Clinic, who reviewed the results, says,
這一結(jié)果是由克利夫蘭診所的心臟病學(xué)家史蒂夫尼森博士評(píng)估的，他說(shuō)
"I can't think of very many times that we've seen a reasonably large clinical trial where we have found a one-third reduction in death."
“在臨床試驗(yàn)中將死亡率降低三分之一的情況真的不多見(jiàn)。”
譯文屬可可英語(yǔ)原創(chuàng)，未經(jīng)允許，不得轉(zhuǎn)載。
